GLP-1 drugs show promise in diabetes management, offering heart and kidney benefits, but also highlight the need for ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Inadequate effectiveness despite reaching target dosage sometimes necessitates reconsideration of medication choice. Different GLP-1 medications and formulations have varying potencies and ...

Just a few years ago, the term “GLP-1” would have been meaningless to most of us. But with the rise of medications like Ozempic and Wegovy, it has become firmly entrenched in our cultural lingo.

Several ongoing studies are looking at the use of GLP-1 medications in type 1 diabetes, Shah says, including one he led, which will be presented in at the American Diabetes Association’s annual ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

These results incrementally burnish orforglipron's potential as the leading oral GLP-1 candidate, a class of drugs with massive market potential if ultimately approved. Pfizer's oral GLP-1 ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

Direct-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1 weight loss drugs for a fraction ... of clinical safety and efficacy to meet their goals, and ...